Dr. Jeremy Richmon is a fellowship-trained head and neck surgeon who specializes in head and neck cancer and microvascular reconstruction. A 2001 graduate of the University of Rochester School of Medicine, Dr. Richmon completed his residency in otolaryngology at the University of California, San Diego, in 2007, and a clinical fellowship in head/neck oncology, microvascular reconstruction, and skull base surgery at Mass. Eye and Ear/Harvard Medical School in 2008. He joined the faculty at Johns Hopkins in 2008 and served as the Director of the Head and Neck Surgery Robotic Program until joining the Mass. Eye and Ear Head and Neck Division as a Clinical Associate and the Harvard Medical School faculty in 2016.
Dr. Richmon has become a pioneer in minimally-invasive robotic techniques in the head and neck. He was the first surgeon to perform transoral robotic surgery at Johns Hopkins in 2009 and developed a robust head and neck robotic surgery program of international renown. He has collaborated with engineers and computer scientists to bring the next generation of robotics into the clinical realm and began the robotic thyroid surgery program at Johns Hopkins. Dr. Richmon was also the first surgeon in the United States to perform transoral robotic thyroidectomy, a technique he helped develop.
Throughout his career, Dr. Richmon has actively participated in resident and fellow education and has been responsible for the development of residency training curriculums specific to head and neck robotic surgery. He sits on the editorial advisory board for Gland Surgery as well as various national head and neck oncology and reconstructive committees. He has been an invited speaker at national and international meetings and has published more than 100 peer-reviewed papers.
Dr. Richmon’s clinical interests include head and neck cancer, skull base surgery, robotic surgery, and microvascular reconstruction of the head and neck. His research interests include microvascular reconstructive techniques of head and neck defects, robotic surgery, and minimally invasive approaches to head and neck problems.
View Dr. Richmon’s robotic surgery videos »
Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma. Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, Lorch JH, Gourin CG, Guo Y, Xiao W, Miles BA, Richmon JD, Andersen PE, Misiukiewicz KJ, Chung CH, Gerber JE, Rajan SD, D'Souza G. JAMA Oncol. 2015 Jul 30.
Long-term functional outcomes of total glossectomy with or without total laryngectomy. Lin DT, Yarlagadda BB, Sethi RK, Feng AL, Shnayder Y, Ledgerwood LG, Diaz JA, Sinha P, Hanasono MM, Yu P, Skoracki RJ, Lian TS, Patel UA, Leibowitz J, Purdy N, Starmer H, Richmon JD. JAMA Otolaryngol Head Neck Surg. 2015 Sep 1. 141(9):797-803.
Augmented reality and cone beam CT guidance for transoral robotic surgery. Liu WP, Richmon JD, Sorger JM, Azizian M, Taylor RH. J Robot Surg. 2015 Sep. 9(3):223-33.
Neck incision planning for total laryngectomy: A finite element analysis. Feng AL, Clark JH, Agrawal N, Moussa W, Richmon JD. J Biomech. 2015 Nov 26. 48(15):4149-54.
Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma. Joseph AW, Guo T, Hur K, Xie Y, Yin L, Califano JA, Ha PK, Quon H, Richmon JD, Eisele DW, Agrawal N, Fakhry C. Head Neck. 2015 Nov 11.
Neck incision planning for total laryngectomy with pharyngectomy. Clark JH, Feng AL, Morton K, Agrawal N, Richmon JD. Otolaryngol Head Neck Surg. 2015 Dec 15.
Predictive factors for prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement and use in head and neck patients following intensity-modulated radiation therapy (IMRT) treatment: Concordance, discrepancies, and the role of gabapentin. Yang W, McNutt TR, Dudley SA, Kumar R, Starmer HM, Gourin CG, Moore JA, Evans K, Allen M, Agrawal N, Richmon JD, Chung CH, Quon H. Dysphagia. 2016 Jan 11.
Changes in unknown primary squamous cell carcinoma of the head and neck at initial presentation in the era of human papillomavirus. Motz K, Qualliotine JR, Rettig E, Richmon JD, Eisele DW, Fakhry C. JAMA Otolaryngol Head Neck Surg. 2016 Jan. 14:1-7.
Rising population of survivors of oral squamous cell cancer in the United States. Patel MA, Blackford AL, Rettig EM, Richmon JD, Eisele DW, Fakhry C. Cancer. 2016 May 1. 122(9):1380-7.
FDG PET/CT in patients with head and neck squamous cell carcinoma after primary surgical resection with or without chemoradiation therapy. Taghipour M, Sheikhbahaei S, Wray R, Agrawal N, Richmon J, Kang H, Subramaniam RM. Am J Roentgenol. 2016 May. 206(5):1093-100.
Management of recurrent malignant salivary neoplasms. Merdad M, Richmon JD, Quon H. Adv Otorhinolaryngol. 2016. 78:168-74.
View a complete list of publications on pubmed.gov »